Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Profession
Dreams and Reality

| Angus Stewart

We hear from the Executive Director of Drugs for Neglected Diseases initiative on his career, the birth of the Drugs for Neglected Diseases Initiative, and the baton he wants to pass on to future generations.

Business & Regulation Contract Manufacturing Services

The New CDMO on the Block

| Stephanie Sutton

Can ten23 health really make a difference to the planet while fully supporting its biopharma customers? We find out.

Discovery & Development COVID-19

Pharma Versus Omicron

| Stephanie Sutton

How will vaccine and therapeutic makers respond to the new SARS-CoV-2 variant?

Register to personalize your newsfeed
Create Account

Latest Articles

Business & Regulation Technology and Equipment

FDA Authorizes VR for Pain Reduction

| Stephanie Sutton

AppliedVR gets FDA OK to market virtual reality system for chronic pain.

Discovery & Development Drug Discovery

The Next Frontier in HIV Prevention

| Maryam Mahdi

Exploring the potential of vaccines for treatment equity.

Business & Regulation Business Practice

Introducing The Medicine Maker Company of the Year Awards

For 2022, we are very excited to launch The Medicine Maker Company of the Year Awards.

Business & Regulation Business Practice

The Power List is Back for 2022!

Nominations are now open for The Medicine Maker 2022 Power List!

Business & Regulation Standards & Regulation

Will it Really Be Built Back Better?

| Stephanie Sutton

A quick look at reactions across the US to Biden’s Build Back Better bill.

Manufacture Vaccines

What's Going On in Vaccines?

| Stephanie Sutton

The latest issue of The Bioprocess Curator included a lot of interesting news about vaccines. In case you missed it, here's some of the top stories.

Manufacture Advanced Medicine

Dreaming of an Efficient Future

Edd Stone of The Technology Partnership outlines current challenges in the cell and gene field - and what we can do about them.

Business & Regulation Business Practice

With Great Power…

| Maryam Mahdi

Environmental, social, and governance (ESG) plans should be an integral part of any company that aims to thrive in today’s society.

Manufacture Advanced Medicine

Mind the Cell and Gene Gap

| Anshul Mangal, Tony Khoury

Anshul Mangal and Tony Khoury of Project Farma weigh in on ways to address the cell and gene therapy skills gap in the US.

Discovery & Development Drug Discovery

Slowing the Alzheimer’s Decline | The Medicine Maker Social

| Maryam Mahdi

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

All Articles

Upcoming Events

2021 ISPE Pharma 4.0™ and Annex 1 Conference

Vienna, Austria

The event brings together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic...

Advanced Therapies Week 2022

Miami, FL, USA

Advanced Therapies Week brings the global advanced therapies community together for the most important week for doing...

Next Generation CAR-TCR Summit

London, UK

The Next Generation CAR-TCR Summit is the industry-dedicated forum focused on the 2.0, next generation innovations in...

All Events

Sister Publications

You might be interested in our Sister Publications:

Discovery & Development
Business & Regulation
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine